- Collagenous colitis
- Crohn's disease
- J Pouch complication
- Lymphocytic colitis
- Microscopic colitis
- Pouchitis
- Ulcerative colitis (UC)
- Colonoscopy
Alexandra Weiss, MD joined the Penn faculty in 2020 after completing her advanced fellowship in inflammatory bowel disease (IBD) at the University of Pennsylvania. She is currently an assistant professor of clinical medicine in the division of Gastroenterology and Hepatology. She has been previously been awarded the GI Clinical Excellence award and the Sydney Kimmel teaching award and maintains a robust clinical practice. Dr. Weiss also serves at the EPIC GI Governance Lead where she integrates her passion for direct patient care with her interest in leveraging technology to improve patient care delivery mechanisms.
Publications
Alexandra Weiss MD, Edward L Barnes MD MPH, Meenakshi Bewtra MD PhD MPH A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's disease , American Journal of Gastroenterology: 2024
James D Lewis, Lauren E Parlett, Michele L Jonsson Funk, Colleen Brensinger, Virginia Pate, Qufei Wu, Ghadeer K Dawwas, Alexandra Weiss, Brad D Constant, Maureen McCauley, Kevin Haynes, Jeff Yufeng Yang, Douglas E Schaubel, Andres Hurtado-Lorenzo, Michael David Kappelman Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States , Gastroenterology: 2023
Thanawala S, Weiss AH, Weber A, Tang H, Buchner A. The role of liver transplant in the development of colorectal dysplasia in patients with PSC-IBD. (Poster Presentation) , DDW: 2023
Weiss AH, Thanawala S, Tang H, Weber A, Buchner A. Severity of inflammation as a risk factor for the development of colorectal dysplasia in PSC-IBD. (Poster Presentation) , DDW: 2023
Weiss, A.H. and Buchner, A.M Editorial: colorectal cancer in elderly-onset inflammatory bowel disease—what is the risk? , Aliment Pharmacol Ther, 56(9): 2022,1421-1422
Mahmud N, Weiss A, Trivedi C, Yang YXm Lewis J, Khan N Risk of venous thromboembolism among patients with inflammatory bowel disease who contract severe acute respiratory syndrome Coronavirus 2 , Gastroenterology, 161: 2021
Weiss AH, Bhattacharya A, Ellison S, Osterman MT, Lichtenstein G Lower Adalimumab trough levels are associated with higher risk of infectious complications in patients with IBD , DDW: 2021
Ellison S, Weiss AH, Bhattacharya A, Osterman MT, Lichtenstein G Adalimumab trough concentration is not associated with adverse events in patients with IBD. , DDW: 2021
Abdulhamid A, Weiss AH, Osterman MT, Lichtenstein G, Buchner A. The outcomes of chromoendoscopy vs. white light HD endoscopy for dysplasia surveillance in Inflammatory Bowel disease patients with primary sclerosing cholangitis (Poster Presentation) , DDW: 2021
Weiss AH, Trivedi C, Pernes T, Patel M, Khan N Incidence of infections and malignancy among elderly IBD patients exposed to vedolizumab, prednisone and mesalamine (Poster Presentation) , DDW: 2021